title: [TREATMENT OF SHORT STATURE PATIENTS WITH NOPMAL GROWTH HORMONE SECRETION OF HYPOPHIS].
abstract: The article presents the treatment outcome in 86 children with short stature associated with different endocrine pathology and saved growth hormone secretion (congenital adrenal hyperplasia chondrodystrophy, Turner syndrome, idiopathic short stature, syndrome biologically inactive growth hormone and other genetically determined pathology). This study extends prior knowledge about the outcomes of the treatment with recombinant growth hormone and luteinizing hormone--releasing hormone analogue (alone or in combination) in short patients with poor prognosis of final height.
authors.forename: N A
authors.initials: NA
authors.lastname: Sprinchuk
authors.forename: O J
authors.initials: OJ
authors.lastname: Samson
authors.forename: E V
authors.initials: EV
authors.lastname: Bol'shova
mesh_terms: D000293:Adolescent; D001827:Body Height / Q000187:drug effects; D002648:Child; D004392:Dwarfism / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010009:Osteochondrodysplasias / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome; D014424:Turner Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology
chemical_list: D007987:Gonadotropin-Releasing Hormone; D013006:Growth Hormone